Celgene Corporation (NASDAQ:CELG) reported operating results for the fourth quarter and full year of 2014. For the fourth quarter of 2014, net product sales were $2,055 million compared to $1,725 million from the same period in 2013, an increase of 19 percent. Fourth quarter total revenue increased 19 percent to $2,085 million compared to $1,756 million in the fourth quarter of 2013. Adjusted net income for the fourth quarter of 2014 increased 29 percent to $840 million compared to $649 million in the fourth quarter of 2013. For the same period, adjusted diluted earnings per share (EPS) increased 33 percent to $1.01 from $0.76, on a stock split-adjusted basis.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
